Literature DB >> 25433469

Challenges and choices in prostate cancer irradiation: from the three dimensional conformal radiotherapy to the era of intensity modulated, image-guided and adaptive radiation treatment.

Maria Aggeliki Kalogeridi1, George Kyrgias1, Anna Zygogianni2, John Kouvaris2, Kyriaki Theodorou1, Nikolaos Kelekis3, Vassilios Kouloulias4.   

Abstract

In the last decades the status of radiotherapy was tremendously increased in terms of conformity to the target as well as image-guided techniques in conjunction with intensity-modulated radiotherapy (IMRT). The technological improvement had a significant clinical outcome for better response and lower toxicity to the surrounding normal tissues. Nowadays the incidence of rectal toxicity has been significantly decreased, especially with image guided radiation therapy (IGRT), whereas the dose escalation to the prostate has driven the clinical practice to the fact that radical radiotherapy for low or intermediate risk prostate cancer is definitely equivalent to surgery. The treatment volume can be reduced by reducing the size of the necessary margins to count for inaccuracies in target position and patient setup. This can be achieved either by improving the daily localization of the target before treatment or by adapting the treatment in response to feedback. This is the goal of image-guided and adaptive radiotherapy, respectively. These techniques improve the accuracy of dose delivery with a significant impact on clinical outcome and toxicity. 

Entities:  

Mesh:

Year:  2014        PMID: 25433469

Source DB:  PubMed          Journal:  Urol J        ISSN: 1735-1308            Impact factor:   1.510


  3 in total

1.  A-blockers for the management of lower urinary tract symptoms in patients with prostate cancer treated with external beam radiotherapy: a randomized controlled study.

Authors:  Kimon Tsirkas; Anna Zygogianni; Andromachi Kougioumtzopoulou; Vasileios Kouloulias; Zoi Liakouli; Athanasios Papatsoris; John Georgakopoulos; Christos Antypas; Christina Armpillia; Athanasios Dellis
Journal:  World J Urol       Date:  2020-08-10       Impact factor: 4.226

2.  Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients.

Authors:  Yiqiao Zhao; Zijia Tao; Lei Li; Jianyi Zheng; Xiaonan Chen
Journal:  BMC Cancer       Date:  2022-03-04       Impact factor: 4.430

3.  Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram.

Authors:  Xin Rui; Siliang Shao; Li Wang; Jiangyong Leng
Journal:  BMC Cancer       Date:  2019-12-03       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.